Victoza is an injectable drug. It is injected daily. It has always had a black box warning linking it to thyroid cancer in rat studies. On June 15, 2011, the FDA issued an official FDA warning regarding pancreatitis as it relates to Vicotza:
“Clinical trials have shown more cases of pancreatitis with liraglutide than with other diabetes drugs, so the FDA recommended patient monitoring after starting liraglutide or raising the dosage, for symptoms such as persistent severe abdominal pain. This pain can sometimes radiate to the back and is accompanied by vomiting.
Liraglutide should be immediately stopped if pancreatitis is suspected and not restarted if the disease is confirmed.
The FDA urged a cautious approach in patients with a history of pancreatitis. The agency also highlighted the contraindication for liraglutide in patients with a personal or family history of medullary thyroid cancer or a personal history of multiple endocrine neoplasia syndrome type 2.”
In addition to informing about the FDA Warning, I want to post the information directly from the opening page of Victoza’s website. The site prominently features Paula Deen on the top of the page, smiling, telling us she uses Victoza to manage her type 2 diabetes.
Important Safety Information
Manage your type 2 diabetes with all positive effects….and not one single dangerous side effect! The Diabetes Miracle.